Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1977 Jan;86(1):183–276.

Acute inflammation. A review.

G B Ryan, G Majno
PMCID: PMC2032041  PMID: 64118

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABLONDI F. B., HAGAN J. J., PHILIPS M., DE RENZO E. C. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid. Arch Biochem Biophys. 1959 May;82(1):153–160. doi: 10.1016/0003-9861(59)90100-6. [DOI] [PubMed] [Google Scholar]
  2. ALLISON F., Jr, SMITH M. R., WOOD W. B., Jr Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J Exp Med. 1955 Dec 1;102(6):655–668. doi: 10.1084/jem.102.6.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ANGGARD ERIK, BERGQVIST U., HOEGBERG B., JOHANSSON K., THON I. L., UVNAES B. BIOLOGICALLY ACTIVE PRINCIPLES OCCURRING ON HISTAMINE RELEASE FROM CAT PAW, GUINEA PIG LUNG AND ISOLATED RAT MAST CELLS. Acta Physiol Scand. 1963 Sep-Oct;59:97–110. doi: 10.1111/j.1748-1716.1963.tb02727.x. [DOI] [PubMed] [Google Scholar]
  4. ARMSTRONG D., KEELE C. A., JEPSON J. B., STEWART J. W. Development of pain-producing substance in human plasma. Nature. 1954 Oct 23;174(4434):791–792. doi: 10.1038/174791a0. [DOI] [PubMed] [Google Scholar]
  5. Adinolfi M. Levels of wo components of complement (C'4 and C'3) in human fetal and newborn sera. Dev Med Child Neurol. 1970 Jun;12(3):306–308. [PubMed] [Google Scholar]
  6. Adler J. Chemoreceptors in bacteria. Science. 1969 Dec 26;166(3913):1588–1597. doi: 10.1126/science.166.3913.1588. [DOI] [PubMed] [Google Scholar]
  7. Agus S. G., Dolin R., Wyatt R. G., Tousimis A. J., Northrup R. S. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med. 1973 Jul;79(1):18–25. doi: 10.7326/0003-4819-79-1-18. [DOI] [PubMed] [Google Scholar]
  8. Allison A. C., Harington J. S., Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966 Aug 1;124(2):141–154. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Allison A. C. The role of microfilaments and microtubules in cell movement, endocytosis and exocytosis. Ciba Found Symp. 1973;14:109–148. doi: 10.1002/9780470719978.ch6. [DOI] [PubMed] [Google Scholar]
  10. Alper C. A., Abramson N., Johnston R. B., Jr, Jandl J. H., Rosen F. S. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med. 1970 Feb 12;282(7):350–354. doi: 10.1056/nejm197002122820701. [DOI] [PubMed] [Google Scholar]
  11. Alper C. A., Rosen F. S., Lachmann P. J. Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910–2913. doi: 10.1073/pnas.69.10.2910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Anggård E., Jonsson C. E. Efflux of prostaglandins in lymph from scalded tissue. Acta Physiol Scand. 1971 Apr;81(4):440–447. doi: 10.1111/j.1748-1716.1971.tb04921.x. [DOI] [PubMed] [Google Scholar]
  13. Appenzeller O., McAndrews E. J. The influence of the central nervous system on the triple reponse of Lewis. J Nerv Ment Dis. 1966 Aug;143(2):190–194. doi: 10.1097/00005053-196608000-00010. [DOI] [PubMed] [Google Scholar]
  14. Armstrong J. A., Hart P. D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 1971 Sep 1;134(3 Pt 1):713–740. doi: 10.1084/jem.134.3.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Astrup T. Tissue activators of plasminogen. Fed Proc. 1966 Jan-Feb;25(1):42–51. [PubMed] [Google Scholar]
  16. Atherton A., Born G. V. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls. J Physiol. 1972 Apr;222(2):447–474. doi: 10.1113/jphysiol.1972.sp009808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Atkins E., Bodel P. Fever. N Engl J Med. 1972 Jan 6;286(1):27–34. doi: 10.1056/NEJM197201062860109. [DOI] [PubMed] [Google Scholar]
  18. Atkins E., Bodel P., Francis L. Release of an endogenous pyrogen in vitro from rabbit mononuclear cells. J Exp Med. 1967 Aug 1;126(2):357–384. doi: 10.1084/jem.126.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Atkins E., Feldman J. D., Francis L., Hursh E. Studies on the mechanism of fever accompanying delayed hypersensitivity. The role of the sensitized lymphocyte. J Exp Med. 1972 May 1;135(5):1113–1132. doi: 10.1084/jem.135.5.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Austen K. F. Systemic anaphylaxis in the human being. N Engl J Med. 1974 Sep 26;291(13):661–664. doi: 10.1056/NEJM197409262911306. [DOI] [PubMed] [Google Scholar]
  21. BANGHAM A. D. THE ADHESIVENESS OF LEUKOCYTES WITH SPECIAL REFERENCES TO ZETA POTENTIAL. Ann N Y Acad Sci. 1964 Aug 27;116:945–949. doi: 10.1111/j.1749-6632.1964.tb52560.x. [DOI] [PubMed] [Google Scholar]
  22. BENNETT I. L., Jr, BEESON P. B. Studies on the pathogenesis of fever. I. The effect of injection of extracts and suspensions of uninfected rabbit tissues upon the body temperature of normal rabbits. J Exp Med. 1953 Nov;98(5):477–492. doi: 10.1084/jem.98.5.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. BENNETT I. L., Jr, BEESON P. B. Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates. J Exp Med. 1953 Nov;98(5):493–508. doi: 10.1084/jem.98.5.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. BERENDES H., BRIDGES R. A., GOOD R. A. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed] [Google Scholar]
  25. BISSET G. W., LEWIS G. P. A spectrum of pharmacological activity in some biologically active peptides. Br J Pharmacol Chemother. 1962 Aug;19:168–182. [PMC free article] [PubMed] [Google Scholar]
  26. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. BROCKLEHURST W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960 Jun;151:416–435. doi: 10.1113/jphysiol.1960.sp006449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. BURKE J. F., MILES A. A. The sequence of vascular events in early infective inflammation. J Pathol Bacteriol. 1958 Jul;76(1):1–19. [PubMed] [Google Scholar]
  29. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Baehner R. L., Johnston R. B., Jr, Nathan D. G. Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc. 1972 Aug;12(2):150–169. [PubMed] [Google Scholar]
  31. Baehner R. L., Karnovsky M. J., Karnovsky M. L. Degranulation of leukocytes in chronic granulomatous disease. J Clin Invest. 1969 Jan;48(1):187–192. doi: 10.1172/JCI105967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Baehner R. L. Molecular basis for functional disorders of phagocytes. J Pediatr. 1974 Mar;84(3):317–327. doi: 10.1016/s0022-3476(74)80711-0. [DOI] [PubMed] [Google Scholar]
  33. Baehner R. L., Nathan D. G., Karnovsky M. L. Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest. 1970 May;49(5):865–870. doi: 10.1172/JCI106305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Baehner R. L., Nathan D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968 May 2;278(18):971–976. doi: 10.1056/NEJM196805022781801. [DOI] [PubMed] [Google Scholar]
  35. Baggiolini M., De Duve C., Masson P. L., Heremans J. F. Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med. 1970 Mar 1;131(3):559–570. doi: 10.1084/jem.131.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Bandmann U., Rydgren L., Norberg B. The difference between random movement and chemotaxis. Effects of antitubulins on neutrophil granulocyte locomotion. Exp Cell Res. 1974 Sep;88(1):63–73. doi: 10.1016/0014-4827(74)90618-1. [DOI] [PubMed] [Google Scholar]
  37. Barat N., de Boisfleury A. Etude de différents paramètres intervenant dans le nécrotactisme des granulocytes après destruction d'un cellule par faisceau laser. Nouv Rev Fr Hematol. 1970 Nov-Dec;10(6):739–746. [PubMed] [Google Scholar]
  38. Becker C. G., Murphy G. E. Demonstration of contractile protein in endothelium and cells of the heart valves, endocardium, intima, arteriosclerotic plaques, and Aschoff bodies of rheumatic heart disease. Am J Pathol. 1969 Apr;55(1):1–37. [PMC free article] [PubMed] [Google Scholar]
  39. Becker E. L., Davis A. T., Estensen R. D., Quie P. G. Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes. J Immunol. 1972 Feb;108(2):396–402. [PubMed] [Google Scholar]
  40. Becker E. L. Enzymatic mechanisms in complement-dependent chemotaxis. Fed Proc. 1969 Sep-Oct;28(5):1704–1709. [PubMed] [Google Scholar]
  41. Becker E. L., Henson P. M. In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Adv Immunol. 1973;17:93–193. doi: 10.1016/s0065-2776(08)60732-4. [DOI] [PubMed] [Google Scholar]
  42. Becker E. L. Phosphonate inhibition of theaccumulation and retention of K+ by rabbit neutrophils in relation to chemotaxis. J Immunol. 1971 Mar;106(3):689–697. [PubMed] [Google Scholar]
  43. Becker E. L. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes. J Exp Med. 1972 Feb 1;135(2):376–387. doi: 10.1084/jem.135.2.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Becker E. L., Ward P. A. Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes. J Exp Med. 1967 Jun 1;125(6):1021–1030. doi: 10.1084/jem.125.6.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Behnke O., Zelander T. Preservation of intercellular substances by the cationic dye alcian blue in preparative procedures for electron microscopy. J Ultrastruct Res. 1970 Jun;31(5-6):424–428. doi: 10.1016/s0022-5320(70)90159-0. [DOI] [PubMed] [Google Scholar]
  46. Bennett B., Bloom B. R. Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A. 1968 Mar;59(3):756–762. doi: 10.1073/pnas.59.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Berenberg J. L., Ward P. A. Chemotactic factor inactivator in normal human serum. J Clin Invest. 1973 May;52(5):1200–1206. doi: 10.1172/JCI107287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Bergström S., Carlson L. A., Weeks J. R. The prostaglandins: a family of biologically active lipids. Pharmacol Rev. 1968 Mar;20(1):1–48. [PubMed] [Google Scholar]
  49. Berlin R. D., Oliver J. M., Ukena T. E., Yin H. H. Control of cell surface topography. Nature. 1974 Jan 4;247(5435):45–46. doi: 10.1038/247045a0. [DOI] [PubMed] [Google Scholar]
  50. Bessis M., Burté B. Positive and negative chemotaxis as observed after the destruction of a cell by U. V. or laser microbeams. Tex Rep Biol Med. 1965 Jun;23(Suppl):204–212. [PubMed] [Google Scholar]
  51. Blaustein M. P., Goldman D. E. Action of anionic and cationic nerve-blocking agents: experiment and interpretation. Science. 1966 Jul 22;153(3734):429–432. doi: 10.1126/science.153.3734.429. [DOI] [PubMed] [Google Scholar]
  52. Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966 Jul 1;153(3731):80–82. doi: 10.1126/science.153.3731.80. [DOI] [PubMed] [Google Scholar]
  53. Bodel P., Atkins E. Release of endogenous pyrogen by human monocytes. N Engl J Med. 1967 May 4;276(18):1002–1008. doi: 10.1056/NEJM196705042761803. [DOI] [PubMed] [Google Scholar]
  54. Boetcher D. A., Leonard E. J. Basophil chemotaxis: augmentation by a factor from stimulated lymphocyte cultures. Immunol Commun. 1973;2(4):421–429. doi: 10.3109/08820137309022813. [DOI] [PubMed] [Google Scholar]
  55. Boggs D. R., Cartwright G. E., Wintrobe M. M. Neutrophilia-inducing activity in plasma of dogs recovering from drug-induced myelotoxicity. Am J Physiol. 1966 Jul;211(1):51–60. doi: 10.1152/ajplegacy.1966.211.1.51. [DOI] [PubMed] [Google Scholar]
  56. Boggs D. R., Chervenick P. A., Marsh J. C., Cartwright G. E., Wintrobe M. M. Neutrophil-releasing activity in plasma of dogs injected with endotoxin. J Lab Clin Med. 1968 Aug;72(2):177–191. [PubMed] [Google Scholar]
  57. Bokisch V. A., Müller-Eberhard H. J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970 Dec;49(12):2427–2436. doi: 10.1172/JCI106462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. doi: 10.1084/jem.129.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Borel J. F., Sorkin E. Differences between plasma and serum mediated chemotaxis of leukocytes. Experientia. 1969 Dec 15;25(12):1333–1335. doi: 10.1007/BF01897535. [DOI] [PubMed] [Google Scholar]
  60. Borel J. F. Studies on chemotaxis. Effect of subcellular leukocyte fractions on neutrophils and macrophages. Int Arch Allergy Appl Immunol. 1970;39(2-3):247–271. [PubMed] [Google Scholar]
  61. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  62. Boxer L. A., Hedley-Whyte E. T., Stossel T. P. Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med. 1974 Nov 21;291(21):1093–1099. doi: 10.1056/NEJM197411212912101. [DOI] [PubMed] [Google Scholar]
  63. Brier A. M., Snyderman R., Mergenhagen S. E., Notkins A. L. Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells. Science. 1970 Dec 4;170(3962):1104–1106. doi: 10.1126/science.170.3962.1104. [DOI] [PubMed] [Google Scholar]
  64. Briggs R. T., Drath D. B., Karnovsky M. L., Karnovsky M. J. Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol. 1975 Dec;67(3):566–586. doi: 10.1083/jcb.67.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Briggs R. T., Karnovsky M. L., Karnovsky M. J. Cytochemical demonstration of hydrogen peroxide in polymorphonuclear leukocyte phagosomes. J Cell Biol. 1975 Jan;64(1):254–260. doi: 10.1083/jcb.64.1.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Bryant R. E., Sutcliffe M. C. A method for quantitation of human leukocyte adhesion to glass. Proc Soc Exp Biol Med. 1972 Oct;141(1):196–202. doi: 10.3181/00379727-141-36741. [DOI] [PubMed] [Google Scholar]
  67. Bryant R. E., Sutcliffe M. C. The effect of 3',5'-adenosine monophosphate on granulocyte adhesion. J Clin Invest. 1974 Nov;54(5):1241–1244. doi: 10.1172/JCI107868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Brånemark P. I., Ekholm R. Adherence of blood cells to vascular endothelium. A vital microscopic and electron microscopic investigation. Blut. 1968 Feb;16(5):274–288. doi: 10.1007/BF01631777. [DOI] [PubMed] [Google Scholar]
  69. Buckley I. K., Ryan G. B. Increased vascular permeability. The effect of histamine and serotonin on rat mesenteric blood vessels in vivo. Am J Pathol. 1969 Jun;55(3):329–347. [PMC free article] [PubMed] [Google Scholar]
  70. Budzko D. B., Bokisch V. A., Müller-Eberhard H. J. A fragment of the third component of human complement with anaphylatoxin activity. Biochemistry. 1971 Mar 30;10(7):1166–1172. doi: 10.1021/bi00783a011. [DOI] [PubMed] [Google Scholar]
  71. CAGAN R. H., KARNOVSKY M. L. ENZYMATIC BASIS OF THE RESPIRATORY STIMULATION DURING PHAGOCYTOSIS. Nature. 1964 Oct 17;204:255–257. doi: 10.1038/204255a0. [DOI] [PubMed] [Google Scholar]
  72. COTRAN R. S., MAJNO G. A LIGHT AND ELECTRON MICROSCOPIC ANALYSIS OF VASCULAR INJURY. Ann N Y Acad Sci. 1964 Aug 27;116:750–764. doi: 10.1111/j.1749-6632.1964.tb52543.x. [DOI] [PubMed] [Google Scholar]
  73. COTRAN R. S. THE DELAYED AND PROLONGED VASCULAR LEAKAGE IN INFLAMMATION. II. AN ELECTRON MICROSCOPIC STUDY OF THE VASCULAR RESPONSE AFTER THERMAL INJURY. Am J Pathol. 1965 Apr;46:589–620. [PMC free article] [PubMed] [Google Scholar]
  74. Caner J. E. Colchicine inhibition of chemotaxis. Arthritis Rheum. 1965 Oct;8(5):757–764. doi: 10.1002/art.1780080438. [DOI] [PubMed] [Google Scholar]
  75. Carraway R., Leeman S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854–6861. [PubMed] [Google Scholar]
  76. Castor C. W. Connective tissue activation. I. The nature, specificity, measurement and distribution of connective tissue activating peptide. Arthritis Rheum. 1971 Jan-Feb;14(1):41–54. doi: 10.1002/art.1780140107. [DOI] [PubMed] [Google Scholar]
  77. Chang C., Houck J. C. Demonstration of the chemotactic properties of collagen. Proc Soc Exp Biol Med. 1970 May;134(1):22–26. doi: 10.3181/00379727-134-34719. [DOI] [PubMed] [Google Scholar]
  78. Chang M. M., Leeman S. E., Niall H. D. Amino-acid sequence of substance P. Nat New Biol. 1971 Jul 21;232(29):86–87. doi: 10.1038/newbio232086a0. [DOI] [PubMed] [Google Scholar]
  79. Clark R. A., Gallin J. I., Kaplan A. P. The selective eosinophil chemotactic activity of histamine. J Exp Med. 1975 Dec 1;142(6):1462–1476. doi: 10.1084/jem.142.6.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Clark R. A., Kimball H. R. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest. 1971 Dec;50(12):2645–2652. doi: 10.1172/JCI106765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Cline M. J., Golde D. W. Production of colony-stimulating activity by human lymphocytes. Nature. 1974 Apr 19;248(5450):703–704. doi: 10.1038/248703a0. [DOI] [PubMed] [Google Scholar]
  82. Cochrane C. G. Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol. 1968;9:97–162. doi: 10.1016/s0065-2776(08)60442-3. [DOI] [PubMed] [Google Scholar]
  83. Cochrane C. G. Mechanisms involved in the deposition of immune complexes in tissues. J Exp Med. 1971 Sep 1;134(3 Pt 2):75s–89s. [PubMed] [Google Scholar]
  84. Cochrane C. G., Müller-Eberhard H. J. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968 Feb 1;127(2):371–386. doi: 10.1084/jem.127.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Cochrane C. G., Revak S. D., Wuepper K. D. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med. 1973 Dec 1;138(6):1564–1583. doi: 10.1084/jem.138.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Cochrane C. G., Revak S. D., Wuepper K. D., Johnston A., Morrison D. C., Ulevitch R. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems. Microvasc Res. 1974 Jul;8(1):112–121. doi: 10.1016/0026-2862(74)90069-7. [DOI] [PubMed] [Google Scholar]
  87. Cochrane C. G., Wuepper K. D., Aiken B. S., Revak S. D., Spiegelberg H. L. The interaction of Hageman factor and immune complexes. J Clin Invest. 1972 Oct;51(10):2736–2745. doi: 10.1172/JCI107093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Cochrane C. G., Wuepper K. D. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). J Exp Med. 1971 Oct 1;134(4):986–1004. doi: 10.1084/jem.134.4.986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Cohen S., Benacerraf B., McCluskey R. T., Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967 Feb;98(2):351–358. [PubMed] [Google Scholar]
  90. Cohen S., Ward P. A. In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med. 1971 Jan 1;133(1):133–146. doi: 10.1084/jem.133.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Cohen S., Ward P. A., Yoshida T., Burek C. L. Biologic activity of extracts of delayed hypersensitivity skin reaction sites. Cell Immunol. 1973 Dec;9(3):363–376. doi: 10.1016/0008-8749(73)90051-8. [DOI] [PubMed] [Google Scholar]
  92. Constantopoulos A., Najjar V. A., Smith J. W. Tuftsin deficiency: a new syndrome with defective phagocytosis. J Pediatr. 1972 Apr;80(4):564–572. doi: 10.1016/s0022-3476(72)80051-9. [DOI] [PubMed] [Google Scholar]
  93. Constantopoulos A., Najjar V. A. Tuftsin deficiency syndrome. A report of two new cases. Acta Paediatr Scand. 1973 Nov;62(6):645–648. doi: 10.1111/j.1651-2227.1973.tb17079.x. [DOI] [PubMed] [Google Scholar]
  94. Cooke P. H., Fay F. S. Correlation between fiber length, ultrastructure, and the length-tension relationship of mammalian smooth muscle. J Cell Biol. 1972 Jan;52(1):105–116. doi: 10.1083/jcb.52.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Cotran R. S. Delayed and prolonged vascular leakage in inflammation. 3. Immediate and delayed vascular reactions in skeletal muscle. Exp Mol Pathol. 1967 Apr;6(2):143–155. doi: 10.1016/0014-4800(67)90052-4. [DOI] [PubMed] [Google Scholar]
  96. Cotran R. S., LaGattuta M., Majno G. Studies on inflammation. Fate of intramural vascular deposits induced by histamine. Am J Pathol. 1965 Dec;47(6):1045–1077. [PMC free article] [PubMed] [Google Scholar]
  97. Cotran R. S. Studies on inflammation. Ultrastructure of the prolonged vascular response induced by Clostridium oedematiens toxin. Lab Invest. 1967 Jul;17(1):39–60. [PubMed] [Google Scholar]
  98. Cotran R. S., Suter E. R., Majno G. The use of colloidal carbon as a tracer for vascular injury. A review. Vasc Dis. 1967 Apr;4(2):107–127. [PubMed] [Google Scholar]
  99. Covino B. G. Local anesthesia. 1. N Engl J Med. 1972 May 4;286(18):975–983. doi: 10.1056/NEJM197205042861805. [DOI] [PubMed] [Google Scholar]
  100. Crockson R. A., Crockson A. P. Relationship of the erythrocyte sedimentation rate to viscosity and plasma proteins in rheumatoid arthritis. Ann Rheum Dis. 1974 Jan;33(1):53–56. doi: 10.1136/ard.33.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Crunkhorn P., Willis A. L. Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol. 1971 Jan;41(1):49–56. doi: 10.1111/j.1476-5381.1971.tb09934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Curnutte J. T., Babior B. M. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest. 1974 Jun;53(6):1662–1672. doi: 10.1172/JCI107717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Curnutte J. T., Whitten D. M., Babior B. M. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med. 1974 Mar 14;290(11):593–597. doi: 10.1056/NEJM197403142901104. [DOI] [PubMed] [Google Scholar]
  104. Currie G. A., Basham C. Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med. 1975 Dec 1;142(6):1600–1605. doi: 10.1084/jem.142.6.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. DONALDSON V. H., EVANS R. R. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. doi: 10.1016/0002-9343(63)90162-1. [DOI] [PubMed] [Google Scholar]
  106. Dalldorf F. G., Keusch G. T., Livingston H. L. Transcellular permeability of capillaries in experimental cholera. Am J Pathol. 1969 Oct;57(1):153–169. [PMC free article] [PubMed] [Google Scholar]
  107. David J. R., David R. R. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy. 1972;16:300–449. [PubMed] [Google Scholar]
  108. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. David J. R. Lymphocyte mediators and cellular hypersensitivity. N Engl J Med. 1973 Jan 18;288(3):143–149. doi: 10.1056/NEJM197301182880311. [DOI] [PubMed] [Google Scholar]
  110. Davis S. D., Schaller J., Wedgwood R. J. Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet. 1966 May 7;1(7445):1013–1015. doi: 10.1016/s0140-6736(66)90119-x. [DOI] [PubMed] [Google Scholar]
  111. DeChatelet L. R., McCall C. E., McPhail L. C., Johnston R. B., Jr Superoxide dismutase activity in leukocytes. J Clin Invest. 1974 Apr;53(4):1197–1201. doi: 10.1172/JCI107659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Di Rosa M., Giroud J. P., Willoughby D. A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971 May;104(1):15–29. doi: 10.1002/path.1711040103. [DOI] [PubMed] [Google Scholar]
  113. Dinarello C. A., Bodel P. T., Atkins E. The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc Am Physicians. 1968;81:334–344. [PubMed] [Google Scholar]
  114. Dinarello C. A., Goldin N. P., Wolff S. M. Demonstration and characterization of two distinct human leukocytic pyrogens. J Exp Med. 1974 Jun 1;139(6):1369–1381. doi: 10.1084/jem.139.6.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Donaldson V. H., Ratnoff O. D., Dias Da Silva W., Rosen F. S. Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest. 1969 Apr;48(4):642–653. doi: 10.1172/JCI106022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Dumonde D. C., Wolstencroft R. A., Panayi G. S., Matthew M., Morley J., Howson W. T. "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969 Oct 4;224(5214):38–42. doi: 10.1038/224038a0. [DOI] [PubMed] [Google Scholar]
  117. Edelman G. M., Yahara I., Wang J. L. Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci U S A. 1973 May;70(5):1442–1446. doi: 10.1073/pnas.70.5.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Estensen R. D., Hill H. R., Quie P. G., Gogan N., Goldberg N. D. Cyclic GMP and cell movement. Nature. 1973 Oct 26;245(5426):458–460. doi: 10.1038/245458a0. [DOI] [PubMed] [Google Scholar]
  119. FEINSTEIN M. B. REACTION OF LOCAL ANESTHETICS WITH PHOSPHOLIPIDS. A POSSIBLE CHEMICAL BASIS FOR ANESTHESIA. J Gen Physiol. 1964 Nov;48:357–374. doi: 10.1085/jgp.48.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. FRUHMAN G. J. EXTRAVASCULAR MOBILIZATION OF NEUTROPHILS. Ann N Y Acad Sci. 1964 Feb 28;113:968–1002. doi: 10.1111/j.1749-6632.1964.tb40717.x. [DOI] [PubMed] [Google Scholar]
  121. Fauve R. M., Hevin B., Jacob H., Gaillard J. A., Jacob F. Antiinflammatory effects of murine malignant cells. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4052–4056. doi: 10.1073/pnas.71.10.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Feldberg W., Gupta K. P. Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid. J Physiol. 1973 Jan;228(1):41–53. doi: 10.1113/jphysiol.1973.sp010071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Feldberg W., Saxena P. N. Fever produced by prostaglandin E1. J Physiol. 1971 Sep;217(3):547–556. doi: 10.1113/jphysiol.1971.sp009585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Ferreira S. H., Flower R. J., Parsons M. F., Vane J. R. Letter: Reduction of the inflammatory response in rats immunized against prostaglandins. Prostaglandins. 1974 Dec 10;8(5):433–437. doi: 10.1016/0090-6980(74)90122-1. [DOI] [PubMed] [Google Scholar]
  125. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  126. Ferreira S. H. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972 Dec 13;240(102):200–203. doi: 10.1038/newbio240200a0. [DOI] [PubMed] [Google Scholar]
  127. Fidalgo B. V., Najjar V. A. The physiological role of the lymphoid system, 3. Leucophilic gamma-globulin and the phagocytic activity of the polymorphonuclear leucocyte. Proc Natl Acad Sci U S A. 1967 Apr;57(4):957–964. doi: 10.1073/pnas.57.4.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Fishman A. P., Pietra G. G. Handling of bioactive materials by the lung (second of two parts). N Engl J Med. 1974 Oct 31;291(18):953–959. doi: 10.1056/NEJM197410312911808. [DOI] [PubMed] [Google Scholar]
  129. GARVIN J. E. Factors affecting the adhesiveness of human leucocytes and platelets in vitro. J Exp Med. 1961 Jul 1;114:51–73. doi: 10.1084/jem.114.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. GORDON A. S., HANDLER E. S., SIEGEL C. D., DORNFEST B. S., LOBUE J. PLASMA FACTORS INFLUENCING LEUKOCYTE RELEASE IN RATS. Ann N Y Acad Sci. 1964 Feb 28;113:766–789. doi: 10.1111/j.1749-6632.1964.tb40703.x. [DOI] [PubMed] [Google Scholar]
  131. Gabbiani G., Badonnel M. C., Mathewson S. M., Ryan G. B. Acute cadmium intoxication. Early selective lesions of endothelial clefts. Lab Invest. 1974 Jun;30(6):686–695. [PubMed] [Google Scholar]
  132. Gabbiani G., Ryan G. B., Lamelin J. P., Vassalli P., Majno G., Bouvier C. A., Cruchaud A., Lüscher E. F. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol. 1973 Sep;72(3):473–488. [PMC free article] [PubMed] [Google Scholar]
  133. Galdston M., Janoff A., Davis A. L. Familial variation of leukocyte lysosomal protease and serum 1 -antitrypsin as determinants in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1973 May;107(5):718–727. doi: 10.1164/arrd.1973.107.5.718. [DOI] [PubMed] [Google Scholar]
  134. Gallin J. I., Durocher J. R., Kaplan A. P. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest. 1975 May;55(5):967–974. doi: 10.1172/JCI108026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Gallin J. I., Kirkpatrick C. H. Chemotactic activity in dialyzable transfer factor. Proc Natl Acad Sci U S A. 1974 Feb;71(2):498–502. doi: 10.1073/pnas.71.2.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Giddon D. B., Lindhe J. In vivo quantitation of local anesthetic suppression of leukocyte adherence. Am J Pathol. 1972 Aug;68(2):327–338. [PMC free article] [PubMed] [Google Scholar]
  137. Gigli I., Kaplan A. P., Austen K. F. Modulation of function of the activated first component of complement by a fragment derived from serum. I. Effect on early components of complement. J Exp Med. 1971 Dec 1;134(6):1466–1484. doi: 10.1084/jem.134.6.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Goetzl E. J., Austen K. F. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J Exp Med. 1972 Dec 1;136(6):1564–1580. doi: 10.1084/jem.136.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Goetzl E. J., Austen K. F. Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J Clin Invest. 1974 Feb;53(2):591–599. doi: 10.1172/JCI107594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Goetzl E. J., Gigli I., Wasserman S., Austen K. F. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J Immunol. 1973 Sep;111(3):938–945. [PubMed] [Google Scholar]
  141. Goetzl E. J., Wasserman S. I., Gigli I., Austen K. F. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest. 1974 Mar;53(3):813–818. doi: 10.1172/JCI107620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Gold S. B., Hanes D. M., Stites D. P., Fudenberg H. H. Abnormal kinetics of degranulation in chronic granulomatous disease. N Engl J Med. 1974 Aug 15;291(7):332–337. doi: 10.1056/NEJM197408152910704. [DOI] [PubMed] [Google Scholar]
  143. Golde D. W., Cline M. J. Regulation of granulopoiesis. N Engl J Med. 1974 Dec 26;291(26):1388–1395. doi: 10.1056/NEJM197412262912606. [DOI] [PubMed] [Google Scholar]
  144. Goldstein I., Hoffstein S., Gallin J., Weissmann G. Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2916–2920. doi: 10.1073/pnas.70.10.2916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Gordon J., MacLean L. D. A lymphocyte-stimulating factor produced in vitro. Nature. 1965 Nov 20;208(5012):795–796. doi: 10.1038/208795a0. [DOI] [PubMed] [Google Scholar]
  146. Gordon S., Unkeless J. C., Cohn Z. A. Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process. J Exp Med. 1974 Oct 1;140(4):995–1010. doi: 10.1084/jem.140.4.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Goren M. B., D'Arcy Hart P., Young M. R., Armstrong J. A. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2510–2514. doi: 10.1073/pnas.73.7.2510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Graham R. C., Jr, Karnovsky M. J., Shafer A. W., Glass E. A., Karnovsky M. L. Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol. 1967 Mar;32(3):629–647. doi: 10.1083/jcb.32.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Granger G. A. Mechanisms of lymphocyte-induced cell and tissue destruction in vitro. Am J Pathol. 1970 Sep;60(3):469–482. [PMC free article] [PubMed] [Google Scholar]
  150. Greaves M. W., McDonald-Gibson W. Itch: role of prostaglandins. Br Med J. 1973 Sep 22;3(5881):608–609. doi: 10.1136/bmj.3.5881.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Greaves M. W., Sondergaard J., McDonald-Gibson W. Recovery of prostaglandins in human cutaneous inflammation. Br Med J. 1971 May 1;2(5756):258–260. doi: 10.1136/bmj.2.5756.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Greaves M. W., Sondergaard J. Pharmacologic agents released in ultraviolet inflammation studied by continuous skin pefusion. J Invest Dermatol. 1970 May;54(5):365–367. doi: 10.1111/1523-1747.ep12259058. [DOI] [PubMed] [Google Scholar]
  153. Greenbaum L. M. Leukocyte kininogenases and leukokinins from normal and malignant cells. Am J Pathol. 1972 Sep;68(3):613–624. [PMC free article] [PubMed] [Google Scholar]
  154. Grimes G. J., Barnes F. S. A technique for studying chemotaxis of leucocytes in well-defined chemotactic fields. Exp Cell Res. 1973 Jun;79(2):375–385. doi: 10.1016/0014-4827(73)90457-6. [DOI] [PubMed] [Google Scholar]
  155. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  156. Götze O., Müller-Eberhard H. J. The role of properdin in the alternate pathway of complement activation. J Exp Med. 1974 Jan 1;139(1):44–57. doi: 10.1084/jem.139.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. HARRIS H. Chemotaxis of granulocytes. J Pathol Bacteriol. 1953 Jul;66(1):135–146. doi: 10.1002/path.1700660117. [DOI] [PubMed] [Google Scholar]
  158. HARRIS H., LOTZ M. Factors influencing chemotaxis of the polymorphonuclear leucocyte. Br J Exp Pathol. 1956 Oct;37(5):477–480. [PMC free article] [PubMed] [Google Scholar]
  159. HARRIS H. Mobilization of defensive cells in inflammatory tissue. Bacteriol Rev. 1960 Mar;24(1):3–15. doi: 10.1128/br.24.1.3-15.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. HARRIS H. Role of chemotaxis in inflammation. Physiol Rev. 1954 Jul;34(3):529–562. doi: 10.1152/physrev.1954.34.3.529. [DOI] [PubMed] [Google Scholar]
  161. HURLEY J. V. ACUTE INFLAMMATION: THE EFFECT OF CONCURRENT LEUCOCYTIC EMIGRATION AND INCREASED PERMEABILITY ON PARTICLE RETENTION BY THE VASCULAR WALL. Br J Exp Pathol. 1964 Dec;45:627–633. [PMC free article] [PubMed] [Google Scholar]
  162. HURLEY J. V. An electron microscopic study of leucocytic emigration and vascular permeability in rat skin. Aust J Exp Biol Med Sci. 1963 Apr;41:171–186. doi: 10.1038/icb.1963.17. [DOI] [PubMed] [Google Scholar]
  163. HURLEY J. V. Incubation of serum with tissue extracts as a cause of chemotaxis of granulocytes. Nature. 1963 Jun 22;198:1212–1213. doi: 10.1038/1981212a0. [DOI] [PubMed] [Google Scholar]
  164. HURLEY J. V., SPECTOR W. G. Delayed leucocytic emigration after intra-dermal injections and thermal injury. J Pathol Bacteriol. 1961 Oct;82:421–429. doi: 10.1002/path.1700820219. [DOI] [PubMed] [Google Scholar]
  165. HURLEY J. V., SPECTOR W. G. Endogenous factors responsible for leucocytic emigration in vivo. J Pathol Bacteriol. 1961 Oct;82:403–420. doi: 10.1002/path.1700820218. [DOI] [PubMed] [Google Scholar]
  166. HURLEY J. V. SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION. Ann N Y Acad Sci. 1964 Aug 27;116:918–935. doi: 10.1111/j.1749-6632.1964.tb52558.x. [DOI] [PubMed] [Google Scholar]
  167. Hahn H. H., Char D. C., Postel W. B., Wood W. B., Jr Studies on the pathogenesis of fever. XV. The production of endogenous pyrogen by peritoneal macrophages. J Exp Med. 1967 Aug 1;126(2):385–394. doi: 10.1084/jem.126.2.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Hahn H. H., Cheuk S. F., Elfenbein S., Wood W. B., Jr Studies on the pathogenesis of fever. XIX. Localization of pyrogen in granulocytes. J Exp Med. 1970 Apr 1;131(4):701–709. doi: 10.1084/jem.131.4.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Ham K. N., Hurley J. V. An electron-microscope study of the vascular response to mild thermal injury in the rat. J Pathol Bacteriol. 1968 Jan;95(1):175–183. doi: 10.1002/path.1700950120. [DOI] [PubMed] [Google Scholar]
  170. Hammersen F. Endothelial filaments and intercellular gaps--a sufficient evidence for contractility? Bibl Anat. 1973;12:159–164. [PubMed] [Google Scholar]
  171. Hashimoto P. H., Takaesu S., Chazono M., Amano T. Vascular leakage through intraendothelial channels induced by cholera toxin in the skin of guinea pigs. Am J Pathol. 1974 Apr;75(1):171–180. [PMC free article] [PubMed] [Google Scholar]
  172. Hausman M. S., Snyderman R., Mergenhagen S. E. Humoral mediators of chemotaxis of mononuclear leukocytes. J Infect Dis. 1972 Jun;125(6):595–602. doi: 10.1093/infdis/125.6.595. [DOI] [PubMed] [Google Scholar]
  173. Hendricks C. H., Brenner W. E., Ekbladh L., Brotanek V., Fishburne J. I., Jr Efficacy and tolerance of intravenous prostaglandins F 2 and E 2 . Am J Obstet Gynecol. 1971 Oct 15;111(4):564–579. doi: 10.1016/0002-9378(71)90473-x. [DOI] [PubMed] [Google Scholar]
  174. Henson P. M. Interaction of cells with immune complexes: adherence, release of constituents, and tissue injury. J Exp Med. 1971 Sep 1;134(3 Pt 2):114s–135s. [PubMed] [Google Scholar]
  175. Henson P. M. Pathologic mechanisms in neutrophil-mediated injury. Am J Pathol. 1972 Sep;68(3):593–612. [PMC free article] [PubMed] [Google Scholar]
  176. Herion J. C., Spitznagel J. K., Walker R. I., Zeya H. I. Pyrogenicity of granulocyte lysosomes. Am J Physiol. 1966 Sep;211(3):693–698. doi: 10.1152/ajplegacy.1966.211.3.693. [DOI] [PubMed] [Google Scholar]
  177. Higgs G. A., Youlten L. J. Proceedings: Prostaglandin production by rabbit peritoneal polymorphonuclear leukocytes in vitro. Br J Pharmacol. 1972 Feb;44(2):330P–330P. [PMC free article] [PubMed] [Google Scholar]
  178. Hill H. R., Ochs H. D., Quie P. G., Clark R. A., Pabst H. F., Klebanoff S. J., Wedgwood R. J. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet. 1974 Sep 14;2(7881):617–619. doi: 10.1016/s0140-6736(74)91942-4. [DOI] [PubMed] [Google Scholar]
  179. Hill H. R., Quie P. G. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet. 1974 Feb 9;1(7850):183–187. doi: 10.1016/s0140-6736(74)92493-3. [DOI] [PubMed] [Google Scholar]
  180. Hill J. H., Ward P. A. C3 leukotactic factors produced by a tissue protease. J Exp Med. 1969 Sep 1;130(3):505–518. doi: 10.1084/jem.130.3.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Hill J. H., Ward P. A. C3 leukotactic factors produced by a tissue protease. J Exp Med. 1969 Sep 1;130(3):505–518. doi: 10.1084/jem.130.3.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Hill J. H., Ward P. A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971 Apr 1;133(4):885–900. doi: 10.1084/jem.133.4.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Hill J. H., Ward P. A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971 Apr 1;133(4):885–900. doi: 10.1084/jem.133.4.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Holmes B., Quie P. G., Windhorst D. B., Good R. A. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet. 1966 Jun 4;1(7449):1225–1228. doi: 10.1016/s0140-6736(66)90238-8. [DOI] [PubMed] [Google Scholar]
  185. Holtermann O. A., Djerassi I., Lisafeld B. A., Elias E. G., Papermaster B. W., Klein E. In vitro destruction of tumor cells by human monocytes. Proc Soc Exp Biol Med. 1974 Nov;147(2):456–459. doi: 10.3181/00379727-147-38363. [DOI] [PubMed] [Google Scholar]
  186. Humbert J. A., Hammond K. B., Hathaway W. E. Trimethylaminuria: the fish-odour syndrome. Lancet. 1970 Oct 10;2(7676):770–771. doi: 10.1016/s0140-6736(70)90241-2. [DOI] [PubMed] [Google Scholar]
  187. Hurley J. V., Ham K. N., Ryan G. B. The mechanism of the delayed prolonged phase of increased vascular permeability in mild thermal injury in the rat. J Pathol Bacteriol. 1967 Jul;94(1):1–12. doi: 10.1002/path.1700940102. [DOI] [PubMed] [Google Scholar]
  188. Hurley J. V., Ryan G. B., Friedman A. The mononuclear response to intrapleural injection in the rat. J Pathol Bacteriol. 1966 Apr;91(2):575–587. doi: 10.1002/path.1700910234. [DOI] [PubMed] [Google Scholar]
  189. Ignarro L. J. Stimulation of phagocytic release of neutral protease from human neutrophils by cholinergic amines and cyclic 3',5'-guanosine monophosphate. J Immunol. 1974 Jan;112(1):210–214. [PubMed] [Google Scholar]
  190. Janoff A., Rosenberg R., Galdston M. Elastase-like, esteroprotease activity in human and rabbit alveolar macrophage granules. Proc Soc Exp Biol Med. 1971 Apr;136(4):1054–1058. doi: 10.3181/00379727-136-35426. [DOI] [PubMed] [Google Scholar]
  191. Jensen J. Anaphylatoxin in its relation to the complement system. Science. 1967 Mar 3;155(3766):1122–1123. doi: 10.1126/science.155.3766.1122. [DOI] [PubMed] [Google Scholar]
  192. Jensen M. S., Bainton D. F. Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte. J Cell Biol. 1973 Feb;56(2):379–388. doi: 10.1083/jcb.56.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Johnston R. B., Jr, Baehner R. L. Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood. 1970 Mar;35(3):350–355. [PubMed] [Google Scholar]
  194. Johnston R. B., Jr, Keele B. B., Jr, Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., RaJagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest. 1975 Jun;55(6):1357–1372. doi: 10.1172/JCI108055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Johnston R. B., Jr, Lehmeyer J. E. Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest. 1976 Apr;57(4):836–841. doi: 10.1172/JCI108359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Jones D. B. The morphology of acid mucosubstances in leukocytic sticking to endothelium in acute inflammation. Lab Invest. 1970 Dec;23(6):606–611. [PubMed] [Google Scholar]
  197. Jones T. C., Hirsch J. G. The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J Exp Med. 1972 Nov 1;136(5):1173–1194. doi: 10.1084/jem.136.5.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. KAGEN L. J., LEDDY J. P., BECKER E. L. THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM. J Clin Invest. 1963 Aug;42:1353–1361. doi: 10.1172/JCI104819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. KARNOVSKY M. L. Metabolic basis of phagocytic activity. Physiol Rev. 1962 Jan;42:143–168. doi: 10.1152/physrev.1962.42.1.143. [DOI] [PubMed] [Google Scholar]
  200. Kaley G., Weiner R. Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci. 1971 Apr 30;180:338–350. doi: 10.1111/j.1749-6632.1971.tb53203.x. [DOI] [PubMed] [Google Scholar]
  201. Kaliner M., Austen K. F. A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J Exp Med. 1973 Nov 1;138(5):1077–1094. doi: 10.1084/jem.138.5.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Kaplan A. P., Austen K. F. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971 Apr 1;133(4):696–712. doi: 10.1084/jem.133.4.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Kaplan A. P., Austen K. F. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med. 1972 Dec 1;136(6):1378–1393. doi: 10.1084/jem.136.6.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Kaplan A. P., Goetzl E. J., Austen K. F. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest. 1973 Oct;52(10):2591–2595. doi: 10.1172/JCI107451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Kaplan A. P., Kay A. B., Austen K. F. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan;135(1):81–97. doi: 10.1084/jem.135.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Kaplan A. P. The Hageman factor dependent pathways of human plasma. Microvasc Res. 1974 Jul;8(1):97–111. doi: 10.1016/0026-2862(74)90068-5. [DOI] [PubMed] [Google Scholar]
  207. Karnovsky M. L. Chronic granulomatous disease--pieces of a cellular and molecular puzzle. Fed Proc. 1973 Apr;32(4):1527–1533. [PubMed] [Google Scholar]
  208. Kasakura S., Lowenstein L. A factor stimulating DNA synthesis derived from the medium of leukocyte cultures. Nature. 1965 Nov 20;208(5012):794–795. doi: 10.1038/208794a0. [DOI] [PubMed] [Google Scholar]
  209. Kay A. B., Austen K. F. Chemotaxis of human basophil leucocytes. Clin Exp Immunol. 1972 Aug;11(4):557–563. [PMC free article] [PubMed] [Google Scholar]
  210. Kay A. B., Austen K. F. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol. 1971 Sep;107(3):899–902. [PubMed] [Google Scholar]
  211. Kay A. B., Pepper D. S., Ewart M. R. Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. Nat New Biol. 1973 May 9;243(123):56–57. [PubMed] [Google Scholar]
  212. Keller H. U., Borel J. F., Wilkinson P. C., Hess M. W., Cottier H. Re-assessment of Boyden's technique for measuring chemotaxis. J Immunol Methods. 1972 Jan;1(2):165–168. doi: 10.1016/0022-1759(72)90043-9. [DOI] [PubMed] [Google Scholar]
  213. Keller H. U., Sorkin E. Studies on chemotaxis. 13. Differences in the chemotactic responses of neutrophil and eosinophil polymorphonuclear leucocytes. Int Arch Allergy Appl Immunol. 1969;35(3):279–287. [PubMed] [Google Scholar]
  214. Klastersky J., Kass E. H. Is suppression of fever or hypothermia useful in experimental and clinical infectious diseases? J Infect Dis. 1970 Jan;121(1):81–86. doi: 10.1093/infdis/121.1.81. [DOI] [PubMed] [Google Scholar]
  215. Klebanoff S. J., Hamon C. B. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc. 1972 Aug;12(2):170–196. [PubMed] [Google Scholar]
  216. Klebanoff S. J. Intraleukocytic microbicidal defects. Annu Rev Med. 1971;22:39–62. doi: 10.1146/annurev.me.22.020171.000351. [DOI] [PubMed] [Google Scholar]
  217. Klebanoff S. J. Iodination of bacteria: a bactericidal mechanism. J Exp Med. 1967 Dec 1;126(6):1063–1078. doi: 10.1084/jem.126.6.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. LANDING B. H., SHIRKEY H. S. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics. 1957 Sep;20(3):431–438. [PubMed] [Google Scholar]
  219. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Lazarus G. S., Daniels J. R., Lian J., Burleigh M. C. Role of granulocyte collagenase in collagen degradation. Am J Pathol. 1972 Sep;68(3):565–578. [PMC free article] [PubMed] [Google Scholar]
  221. Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969 Aug;48(8):1478–1488. doi: 10.1172/JCI106114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Lehrer R. I. Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J Clin Invest. 1971 Dec;50(12):2498–2505. doi: 10.1172/JCI106750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Leibovich S. J., Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976 Sep;84(3):501–514. [PMC free article] [PubMed] [Google Scholar]
  224. Lepow I. H., Willms-Kretschmer K., Patrick R. A., Rosen F. S. Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol. 1970 Oct;61(1):13–23. [PMC free article] [PubMed] [Google Scholar]
  225. Lewis G. P., Piper P. J. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature. 1975 Mar 27;254(5498):308–311. doi: 10.1038/254308a0. [DOI] [PubMed] [Google Scholar]
  226. Lolekha S., Dray S., Gotoff S. P. Macrophage aggregation in vitro: a correlate of delayed hypersensitivity. J Immunol. 1970 Feb;104(2):296–304. [PubMed] [Google Scholar]
  227. Lubaroff D. M., Waksman B. H. Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems. J Exp Med. 1968 Dec 1;128(6):1425–1435. doi: 10.1084/jem.128.6.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Lubaroff D. M., Waksman B. H. Bone marrow as source of cells in reactions of cellular hypersensitivity. II. Identification of allogeneic or hybrid cells by immunofluorescence in passively transferred tuberculin reactions. J Exp Med. 1968 Dec 1;128(6):1437–1447. doi: 10.1084/jem.128.6.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Luft J. H. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc. 1966 Nov-Dec;25(6):1773–1783. [PubMed] [Google Scholar]
  230. Lundh B., Laurell A. B., Wetterqvist H., White T., Granerus G. A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism. Clin Exp Immunol. 1968 Sep;3(7):733–745. [PMC free article] [PubMed] [Google Scholar]
  231. MAJNO G., PALADE G. E., SCHOEFL G. I. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol. 1961 Dec;11:607–626. doi: 10.1083/jcb.11.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. MAJNO G., PALADE G. E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961 Dec;11:571–605. doi: 10.1083/jcb.11.3.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. MARCHESI V. T., FLOREY H. W. Electron micrographic observations on the emigration of leucocytes. Q J Exp Physiol Cogn Med Sci. 1960 Oct;45:343–348. doi: 10.1113/expphysiol.1960.sp001489. [DOI] [PubMed] [Google Scholar]
  234. MARCHESI V. T., GOWANS J. L. THE MIGRATION OF LYMPHOCYTES THROUGH THE ENDOTHELIUM OF VENULES IN LYMPH NODES: AN ELECTRON MICROSCOPE STUDY. Proc R Soc Lond B Biol Sci. 1964 Jan 14;159:283–290. doi: 10.1098/rspb.1964.0002. [DOI] [PubMed] [Google Scholar]
  235. MARCHESI V. T. The site of leucocyte emigration during inflammation. Q J Exp Physiol Cogn Med Sci. 1961 Apr;46:115–118. doi: 10.1113/expphysiol.1961.sp001522. [DOI] [PubMed] [Google Scholar]
  236. MARGOLIS J. Hagerman factor and capillary permeability. Aust J Exp Biol Med Sci. 1959 Jun;37:239–244. doi: 10.1038/icb.1959.24. [DOI] [PubMed] [Google Scholar]
  237. MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
  238. MOVAT H. Z., FERNANDO N. V. ACUTE INFLAMMATION. THE EARLIEST FINE STRUCTURAL CHANGES AT THE BLOOD-TISSUE BARRIER. Lab Invest. 1963 Sep;12:895–910. [PubMed] [Google Scholar]
  239. MOVAT H. Z., MORE R. H., WOLOCHOW D. Cellular and intercellular changes after mechanical, chemical or radiation injury of connective tissue. Br J Exp Pathol. 1960 Apr;41:97–104. [PMC free article] [PubMed] [Google Scholar]
  240. MacGregor R. R., Spagnuolo P. J., Lentnek A. L. Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. N Engl J Med. 1974 Sep 26;291(13):642–646. doi: 10.1056/NEJM197409262911302. [DOI] [PubMed] [Google Scholar]
  241. Macnab R. M., Koshland D. E., Jr The gradient-sensing mechanism in bacterial chemotaxis. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2509–2512. doi: 10.1073/pnas.69.9.2509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Majno G., Gilmore V., Leventhal M. On the mechanism of vascular leakage caused by histaminetype mediators. A microscopic study in vivo. Circ Res. 1967 Dec;21(6):833–847. doi: 10.1161/01.res.21.6.833. [DOI] [PubMed] [Google Scholar]
  243. Majno G., Shea S. M., Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol. 1969 Sep;42(3):647–672. doi: 10.1083/jcb.42.3.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Malawista S. E., Bodel P. T. The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes. J Clin Invest. 1967 May;46(5):786–796. doi: 10.1172/JCI105579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Mandell G. L., Rubin W., Hook E. W. The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest. 1970 Jul;49(7):1381–1388. doi: 10.1172/JCI106355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Margaretten W., Howes E. L., Jr, McKay D. G. The effect of shock on the inflammatory response. A reevaluation of the role of platelets in the active arthus reaction. Am J Pathol. 1975 Jan;78(1):159–170. [PMC free article] [PubMed] [Google Scholar]
  247. McCall C. E., Caves J., Cooper R., DeChatlet L. Functional characteristics of human toxic neutrophils. J Infect Dis. 1971 Jul;124(1):68–75. doi: 10.1093/infdis/124.1.68. [DOI] [PubMed] [Google Scholar]
  248. McCall C. E., Katayama I., Cotran R. S., Finland M. Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med. 1969 Feb 1;129(2):267–293. doi: 10.1084/jem.129.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. McQueen A., Hurley J. V. Aspects of increased vascular permeability following the intradermal injections of histamine in the rat. Pathology. 1971 Jul;3(3):191–202. [PubMed] [Google Scholar]
  250. Medicus R. G., Schreiber R. D., Götze O., Müller-Eberhard H. J. A molecular concept of the properdin pathway. Proc Natl Acad Sci U S A. 1976 Feb;73(2):612–616. doi: 10.1073/pnas.73.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Messina E. J., Weiner R., Kaley G. Microcirculatory effects of prostaglandins E1, E2, and A1 in the rat mesentery and cremaster muscle. Microvasc Res. 1974 Jul;8(1):77–89. doi: 10.1016/0026-2862(74)90066-1. [DOI] [PubMed] [Google Scholar]
  252. Mickenberg I. D., Root R. K., Wolff S. M. Bactericidal and metabolic properties of human eosinophils. Blood. 1972 Jan;39(1):67–80. [PubMed] [Google Scholar]
  253. Mickenberg I. D., Snyderman R., Root R. K., Mergenhagen S. E., Wolff S. M. Immune fever in the rabbit: responses of the hematologic and complement systems. J Immunol. 1971 Nov;107(5):1457–1465. [PubMed] [Google Scholar]
  254. Mickenberg I. D., Snyderman R., Root R. K., Mergenhagen S. E., Wolff S. M. The relationship of complement consumption to immune fever. J Immunol. 1971 Nov;107(5):1466–1476. [PubMed] [Google Scholar]
  255. Miles A. D. The kinin system. A history and review of the kinin system. Proc R Soc Lond B Biol Sci. 1969 Jul 1;173(1032):341–349. doi: 10.1098/rspb.1969.0060. [DOI] [PubMed] [Google Scholar]
  256. Miller M. E., Nilsson U. R. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med. 1970 Feb 12;282(7):354–358. doi: 10.1056/NEJM197002122820702. [DOI] [PubMed] [Google Scholar]
  257. Miller M. E., Norman M. E., Koblenzer P. J., Schonauer T. A new familial defect of neutrophil movement. J Lab Clin Med. 1973 Jul;82(1):1–8. [PubMed] [Google Scholar]
  258. Miller M. E., Oski F. A., Harris M. B. Lazy-leucocyte syndrome. A new disorder of neutrophil function. Lancet. 1971 Apr 3;1(7701):665–669. doi: 10.1016/s0140-6736(71)92679-1. [DOI] [PubMed] [Google Scholar]
  259. Miller T. E. Killing and lysis of gram-negative bacteria through the synergistic effect of hydrogen peroxide, ascorbic acid, and lysozyme. J Bacteriol. 1969 Jun;98(3):949–955. doi: 10.1128/jb.98.3.949-955.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Milton A. S., Wendlandt S. Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J Physiol. 1971 Oct;218(2):325–336. doi: 10.1113/jphysiol.1971.sp009620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Moncada S., Ferreira S. H., Vane J. R. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature. 1973 Nov 23;246(5430):217–219. doi: 10.1038/246217a0. [DOI] [PubMed] [Google Scholar]
  262. Moore D. M., Murphy P. A., Chesney P. J., Wood W. B., Jr Synthesis of endogenous pyrogen by rabbit leukocytes. J Exp Med. 1973 May 1;137(5):1263–1274. doi: 10.1084/jem.137.5.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Morrison D. C., Cochrane C. G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med. 1974 Sep 1;140(3):797–811. doi: 10.1084/jem.140.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Movat H. Z. Chemical mediators of the vascular phenomena of the acute inflammatory reaction and of immediate hypersensitivity. Med Clin North Am. 1972 Mar;56(2):541–556. doi: 10.1016/s0025-7125(16)32413-0. [DOI] [PubMed] [Google Scholar]
  265. Movat H. Z., Steinberg S. G., Habal F. M., Ranadive N. S. Demonstration of a kinin-generating enzyme in the lysosomes of human polymorphonuclear leukocytes. Lab Invest. 1973 Dec;29(6):669–684. [PubMed] [Google Scholar]
  266. Mowat A. G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Invest. 1971 Dec;50(12):2541–2549. doi: 10.1172/JCI106754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Mowat A., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971 Mar 25;284(12):621–627. doi: 10.1056/NEJM197103252841201. [DOI] [PubMed] [Google Scholar]
  268. Muller H. K., Salasoo I., Logounov E., Wilhelm D. L. The mediation of increased vascular permeability in inflammation: a long-acting permeability factor released by neutrophil leucocytes from inflammatory exudates in the rabbit. Pathology. 1974 Apr;6(2):129–141. doi: 10.3109/00313027409068976. [DOI] [PubMed] [Google Scholar]
  269. Muller H. K., Salasoo I., Wilhelm D. L. The mediation of increased vascular permeability in inflammation. I. A long-acting permeability factor in rabbit serum. Aust J Exp Biol Med Sci. 1968 Apr;46(2):165–177. doi: 10.1038/icb.1968.14. [DOI] [PubMed] [Google Scholar]
  270. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  271. Müller-Eberhard H. J. Complement. Annu Rev Biochem. 1969;38:389–414. doi: 10.1146/annurev.bi.38.070169.002133. [DOI] [PubMed] [Google Scholar]
  272. Najjar V. A., Fidalgo B. V., Stitt E. The physiological role of the lymphoid system. VII. The disappearance of leucokinin activity following splenectomy. Biochemistry. 1968 Jun;7(6):2376–2379. doi: 10.1021/bi00846a046. [DOI] [PubMed] [Google Scholar]
  273. Najjar V. A., Nishioka K. "Tuftsin": a natural phagocytosis stimulating peptide. Nature. 1970 Nov 14;228(5272):672–673. doi: 10.1038/228672a0. [DOI] [PubMed] [Google Scholar]
  274. Nathan C. F., Karnovsky M. L., David J. R. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971 Jun 1;133(6):1356–1376. doi: 10.1084/jem.133.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Nishiura M., Yamamoto S., Hayashi H. The natural mediator for PMN emigration in inflammation. VI. Production of leucoegresin by inflammatory SH-dependent protease in active Arthus reactions in complement-depleted rabbits. Immunology. 1974 Dec;27(6):1023–1031. [PMC free article] [PubMed] [Google Scholar]
  276. Norris H. T. Back to parenchymal inflammation? Pathogenesis of fluid production by the ileum in experimental cholera: an unusual type of host response to bacterial agents. Biochem Pharmacol. 1968 Mar;(Suppl):133–141. doi: 10.1016/0006-2952(68)90300-6. [DOI] [PubMed] [Google Scholar]
  277. Norris H. T., Majno G. On the role of the ileal epithelium in the pathogenesis of experimental cholera. Am J Pathol. 1968 Aug;53(2):263–279. [PMC free article] [PubMed] [Google Scholar]
  278. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity. J Exp Med. 1976 Mar 1;143(3):574–584. doi: 10.1084/jem.143.3.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  279. OSBAHR A. J., GLADNER J. A., LAKI K. STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION. Biochim Biophys Acta. 1964 Jun 8;86:535–542. doi: 10.1016/0304-4165(64)90093-5. [DOI] [PubMed] [Google Scholar]
  280. Orange R. P., Austen K. F. Slow reacting substance of anaphylaxis. Adv Immunol. 1969;10:105–144. doi: 10.1016/s0065-2776(08)60416-2. [DOI] [PubMed] [Google Scholar]
  281. Orange R. P., Murphy R. C., Austen K. F. Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases. J Immunol. 1974 Jul;113(1):316–322. [PubMed] [Google Scholar]
  282. Orange R. P., Murphy R. C., Karnovsky M. L., Austen K. F. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol. 1973 Mar;110(3):760–770. [PubMed] [Google Scholar]
  283. Oronsky A., Ignarro L., Perper R. Release of cartilage mucopolysaccharide-degrading neutral protease from human leukocytes. J Exp Med. 1973 Aug 1;138(2):461–472. doi: 10.1084/jem.138.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Osler A. G., Siraganian R. P. Immunologic mechanisms of platelet damage. Prog Allergy. 1972;16:450–498. [PubMed] [Google Scholar]
  285. PAZ R. A., SPECTOR W. G. The mononuclear-cell response to injury. J Pathol Bacteriol. 1962 Jul;84:85–103. doi: 10.1002/path.1700840111. [DOI] [PubMed] [Google Scholar]
  286. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  288. Papahadjopoulos D. Studies on the mechanism of action of local anesthetics with phospholipid model membranes. Biochim Biophys Acta. 1972 Apr 18;265(2):169–186. doi: 10.1016/0304-4157(72)90001-9. [DOI] [PubMed] [Google Scholar]
  289. Parker J. W., Metcalf D. Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures. J Immunol. 1974 Feb;112(2):502–510. [PubMed] [Google Scholar]
  290. Perlmann P., Perlmann H., Müller-Eberhard H. J., Manni J. A. Cytotoxic effects of leukocyres triggered by complement bound to target cells. Science. 1969 Feb 28;163(3870):937–939. doi: 10.1126/science.163.3870.937. [DOI] [PubMed] [Google Scholar]
  291. Phelps P. Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 1969 Jun;12(3):197–204. doi: 10.1002/art.1780120306. [DOI] [PubMed] [Google Scholar]
  292. Pike J. E. Prostaglandins. Sci Am. 1971 Nov;225(5):84–93. doi: 10.1038/scientificamerican1171-84. [DOI] [PubMed] [Google Scholar]
  293. Pollard T. D., Weihing R. R. Actin and myosin and cell movement. CRC Crit Rev Biochem. 1974 Jan;2(1):1–65. doi: 10.3109/10409237409105443. [DOI] [PubMed] [Google Scholar]
  294. Prokopowicz J. Distribution of fibrinolytic and proteolytic enzymes in subcellular fractions of human granulocytes. Thromb Diath Haemorrh. 1968 Mar 31;19(1):84–93. [PubMed] [Google Scholar]
  295. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. RATNOFF O. D., LEPOW I. H. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE. J Exp Med. 1963 Nov 1;118:681–698. doi: 10.1084/jem.118.5.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  297. RONA G., CHAPPEL C. I., KAHN D. Experimental production of chronic cardiac aneurysm and congestive heart failure in the rat. Exp Mol Pathol. 1963 Feb;2:40–51. doi: 10.1016/0014-4800(63)90005-4. [DOI] [PubMed] [Google Scholar]
  298. ROWLEY D. A. VENOUS CONSTRICTION AS THE CAUSE OF INCREASED VASCULAR PERMEABILITY PRODUCED BY 5-HYDROXYTRYPTAMINE, HISTAMINE, BRADYKININ AND 48/80 IN THE RAT. Br J Exp Pathol. 1964 Feb;45:56–67. [PMC free article] [PubMed] [Google Scholar]
  299. Ramsey W. S. Analysis of individual leucocyte behavior during chemotaxis.. Exp Cell Res. 1972 Jan;70(1):129–139. doi: 10.1016/0014-4827(72)90190-5. [DOI] [PubMed] [Google Scholar]
  300. Ranadive N. S., Cochrane C. G. Basic proteins in rat neutrophils that increase vascular permeability. Clin Exp Immunol. 1970 Jun;6(6):905–911. [PMC free article] [PubMed] [Google Scholar]
  301. Ranadive N. S., Cochrane C. G. Isolation and characterization of permeability factors from rabbit neutrophils. J Exp Med. 1968 Oct 1;128(4):605–622. doi: 10.1084/jem.128.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Ranadive N. S., Cochrane C. G. Mechanism of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes. J Immunol. 1971 Feb;106(2):506–516. [PubMed] [Google Scholar]
  303. Ratnoff O. D. INCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN. J Exp Med. 1965 Oct 31;122(5):905–921. doi: 10.1084/jem.122.5.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  304. Ratnoff O. D., Naff G. B. The conversion of C'IS to C'1 esterase by plasmin and trypsin. J Exp Med. 1967 Feb 1;125(2):337–358. doi: 10.1084/jem.125.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  305. Ratnoff O. D., Pensky J., Ogston D., Naff G. B. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med. 1969 Feb 1;129(2):315–331. doi: 10.1084/jem.129.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  306. Ratnoff O. D. Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Adv Immunol. 1969;10:145–227. doi: 10.1016/s0065-2776(08)60417-4. [DOI] [PubMed] [Google Scholar]
  307. Reed P. W. Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes. J Biol Chem. 1969 May 10;244(9):2459–2464. [PubMed] [Google Scholar]
  308. Rossi F., Romeo D., Patriarca P. Mechanism of phagocytosis-associated oxidative metabolism in polymorphonuclear leucocytes and macrophages. J Reticuloendothel Soc. 1972 Aug;12(2):127–149. [PubMed] [Google Scholar]
  309. Rother K. Leucocyte mobilizing factor: a new biological activity derived from the third component of complement. Eur J Immunol. 1972 Dec;2(6):550–558. doi: 10.1002/eji.1830020615. [DOI] [PubMed] [Google Scholar]
  310. Ruddy S., Gigli I., Austen K. F. The complement system of man. 4. N Engl J Med. 1972 Sep 28;287(13):642–646. doi: 10.1056/NEJM197209282871306. [DOI] [PubMed] [Google Scholar]
  311. Russell R. J., Wilkinson P. C., Sless F., Parrott D. M. Chemotaxis of lymphoblasts. Nature. 1975 Aug 21;256(5519):646–648. doi: 10.1038/256646a0. [DOI] [PubMed] [Google Scholar]
  312. Ryan G. B., Borysenko J. Z., Karnovsky M. J. Factors affecting the redistribution of surface-bound concanavalin A on human polymorphonuclear leukocytes. J Cell Biol. 1974 Aug;62(2):351–365. doi: 10.1083/jcb.62.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  313. Ryan G. B., Grobéty J., Majno G. Mesothelial injury and recovery. Am J Pathol. 1973 Apr;71(1):93–112. [PMC free article] [PubMed] [Google Scholar]
  314. Ryan G. B., Hurley J. V. The chemotaxis of polymorphonuclear leucocytes towards damaged tissue. Br J Exp Pathol. 1966 Oct;47(5):530–536. [PMC free article] [PubMed] [Google Scholar]
  315. Ryan G. B., Hurley J. V. The drug inhibition of increased vascular permeability. J Pathol Bacteriol. 1968 Oct;96(2):371–379. doi: 10.1002/path.1700960215. [DOI] [PubMed] [Google Scholar]
  316. Ryan G. B. Inflammation. Mediators of inflammation. Beitr Pathol. 1974;152(3):272–291. [PubMed] [Google Scholar]
  317. Ryan G. B. The origin and sequence of the cells found in the acute inflammatory response. Aust J Exp Biol Med Sci. 1967 Apr;45(2):149–162. doi: 10.1038/icb.1967.12. [DOI] [PubMed] [Google Scholar]
  318. Ryan G. B., Unanue E. R., Karnovsky M. J. Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers. Nature. 1974 Jul 5;250(461):56–57. doi: 10.1038/250056a0. [DOI] [PubMed] [Google Scholar]
  319. SELYE H. Nonspecific resistance. Ergeb Allg Pathol Pathol Anat. 1961;41:208–241. [PubMed] [Google Scholar]
  320. SEVITT S. Early and delayed oedema and increase in capillary permeability after burns of the skin. J Pathol Bacteriol. 1958 Jan;75(1):27–37. doi: 10.1002/path.1700750105. [DOI] [PubMed] [Google Scholar]
  321. Salin M. L., McCord J. M. Superoxide dismutases in polymorphonuclear leukocytes. J Clin Invest. 1974 Oct;54(4):1005–1009. doi: 10.1172/JCI107816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Schoefl G. I. The migration of lymphocytes across the vascular endothelium in lymphoid tissue. A reexamination. J Exp Med. 1972 Sep 1;136(3):568–588. doi: 10.1084/jem.136.3.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  323. Schreiber D. S., Blacklow N. R., Trier J. S. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med. 1973 Jun 21;288(25):1318–1323. doi: 10.1056/NEJM197306212882503. [DOI] [PubMed] [Google Scholar]
  324. Schreiber D. S., Blacklow N. R., Trier J. S. The small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J Infect Dis. 1974 Jun;129(6):705–708. doi: 10.1093/infdis/129.6.705. [DOI] [PubMed] [Google Scholar]
  325. Seeman P. M. Membrane stabilization by drugs: tranquilizers, steroids, and anesthetics. Int Rev Neurobiol. 1966;9:145–221. doi: 10.1016/s0074-7742(08)60138-5. [DOI] [PubMed] [Google Scholar]
  326. Segal A. W. Nitroblue-tetrazolium tests. Lancet. 1974 Nov 23;2(7891):1248–1252. doi: 10.1016/s0140-6736(74)90758-2. [DOI] [PubMed] [Google Scholar]
  327. Senda N., Shibata N., Tatsumi N., Kondo K., Hamada K. A contractile protein from leucocytes. Its extraction and some of its properties. Biochim Biophys Acta. 1969 May;181(1):191–200. doi: 10.1016/0005-2795(69)90241-4. [DOI] [PubMed] [Google Scholar]
  328. Shea S. M., Caulfield J. B., Burke J. F. Microvascular ultrastructure in thermal injury: a reconsideration of the role of mediators. Microvasc Res. 1973 Jan;5(1):87–96. doi: 10.1016/s0026-2862(73)80010-x. [DOI] [PubMed] [Google Scholar]
  329. Simionescu M., Simionescu N., Palade G. E. Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol. 1975 Dec;67(3):863–885. doi: 10.1083/jcb.67.3.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  330. Simionescu N., Siminoescu M., Palade G. E. Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels. J Cell Biol. 1975 Mar;64(3):586–607. doi: 10.1083/jcb.64.3.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Smith C. W., Hollers J. C., Dupree E., Goldman A. S., Lord R. A. A serum inhibitor of leukotaxis in a child with recurrent infections. J Lab Clin Med. 1972 Jun;79(6):878–885. [PubMed] [Google Scholar]
  332. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  333. Snyderman R., Phillips J., Mergenhagen S. E. Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun. 1970 Jun;1(6):521–525. doi: 10.1128/iai.1.6.521-525.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  334. Snyderman R., Shin H. S., Hausman M. H. A chemotactic factor for mononuclear leukocytes. Proc Soc Exp Biol Med. 1971 Nov;138(2):387–390. doi: 10.3181/00379727-138-35903. [DOI] [PubMed] [Google Scholar]
  335. Snyderman R., Shin H. S., Phillips J. K., Gewurz H., Mergenhagen S. E. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol. 1969 Sep;103(3):413–422. [PubMed] [Google Scholar]
  336. Stecher V. J., Sorkin E. Studies on chemotaxis. XII. Generation of chemotactic activity for polymorphonuclear leucocytes in sera with complement dificiencies. Immunology. 1969 Feb;16(2):231–239. [PMC free article] [PubMed] [Google Scholar]
  337. Stecher V. J., Sorkin E. The chemotactic activity of fibrin lysis products. Int Arch Allergy Appl Immunol. 1972;43(6):879–886. doi: 10.1159/000230905. [DOI] [PubMed] [Google Scholar]
  338. Stewart G. J., Ritchie W. G., Lynch P. R. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol. 1974 Mar;74(3):507–532. [PMC free article] [PubMed] [Google Scholar]
  339. Stossel T. P. Phagocytosis (third of three parts). N Engl J Med. 1974 Apr 11;290(15):833–839. doi: 10.1056/NEJM197404112901506. [DOI] [PubMed] [Google Scholar]
  340. Stossel T. P. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin. J Cell Biol. 1973 Aug;58(2):346–356. doi: 10.1083/jcb.58.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  341. Stossel T. P., Root R. K., Vaughan M. Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome. N Engl J Med. 1972 Jan 20;286(3):120–123. doi: 10.1056/NEJM197201202860302. [DOI] [PubMed] [Google Scholar]
  342. Symon D. N., McKay I. C., Wilkinson P. C. Plasma-dependent chemotaxis of macrophages towards mycobacterium tuberculosis and other organisms. Immunology. 1972 Feb;22(2):267–276. [PMC free article] [PubMed] [Google Scholar]
  343. Talstad I. The mechanism of the erythrocyte sedimentation rate (ESR). Acta Med Scand. 1971 Jul-Aug;190(1-2):11–16. doi: 10.1111/j.0954-6820.1971.tb07388.x. [DOI] [PubMed] [Google Scholar]
  344. Thompson P. L., Papadimitriou J. M., Walters M. N. Suppression of leucocytic sticking and emigration by chelation of calcium. J Pathol Bacteriol. 1967 Oct;94(2):389–396. doi: 10.1002/path.1700940219. [DOI] [PubMed] [Google Scholar]
  345. Tregear G. W., Niall H. D., Potts J. T., Jr, Leeman S. E., Chang M. M. Synthesis of substance P. Nat New Biol. 1971 Jul 21;232(29):87–89. doi: 10.1038/newbio232087a0. [DOI] [PubMed] [Google Scholar]
  346. Tsan M. F., Berlin R. D. Effect of phagocytosis on membrane transport of nonelectrolytes. J Exp Med. 1971 Oct 1;134(4):1016–1035. doi: 10.1084/jem.134.4.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. Ukena T. E., Berlin R. D. Effect of colchicine and vinblastine on the topographical separation of membrane functions. J Exp Med. 1972 Jul 1;136(1):1–7. doi: 10.1084/jem.136.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Unanue E. R. Secretory function of mononuclear phagocytes: a review. Am J Pathol. 1976 May;83(2):396–418. [PMC free article] [PubMed] [Google Scholar]
  349. V Euler U. S., Gaddum J. H. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931 Jun 6;72(1):74–87. doi: 10.1113/jphysiol.1931.sp002763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. VASSALLI P., MCCLUSKEY R. T. THE COAGULATION PROCESS AND GLOMERULAR DISEASE. Am J Med. 1965 Aug;39:179–183. doi: 10.1016/0002-9343(65)90040-9. [DOI] [PubMed] [Google Scholar]
  351. VOGLER K., HAEFELY W., HURLIMANN A., STUDER R. O., LERGIER W., STRASSLE R., BERNEIS K. H. A new purification procedure and biological properties of substance P. Ann N Y Acad Sci. 1963 Feb 4;104:378–390. doi: 10.1111/j.1749-6632.1963.tb17682.x. [DOI] [PubMed] [Google Scholar]
  352. Vallota E. H., Müller-Eberhard H. J. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med. 1973 May 1;137(5):1109–1123. doi: 10.1084/jem.137.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  353. Van Snick J. L., Masson P. L., Heremans J. F. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med. 1974 Oct 1;140(4):1068–1084. doi: 10.1084/jem.140.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  355. Vinegar R. Quantitative studies concerning kaolin edema formation in rats. J Pharmacol Exp Ther. 1968 Jun;161(2):389–395. [PubMed] [Google Scholar]
  356. Vinegar R., Schreiber W., Hugo R. Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther. 1969 Mar;166(1):96–103. [PubMed] [Google Scholar]
  357. WALTERS M. N., WILLOUGHBY D. A. THE EFFECT OF TISSUE EXTRACTS ON VASCULAR PERMEABILITY AND LEUCOCYTE EMIGRATION. J Pathol Bacteriol. 1965 Jan;89:255–262. doi: 10.1002/path.1700890126. [DOI] [PubMed] [Google Scholar]
  358. WELLS F. R., MILES A. A. SITE OF THE VASCULAR RESPONSE TO THERMAL INJURY. Nature. 1963 Dec 7;200:1015–1016. doi: 10.1038/2001015a0. [DOI] [PubMed] [Google Scholar]
  359. WILLOUGHBY D. A., BOUGHTON B., SPECTOR W. G., SCHILD H. O. A vascular permeability factor extracted from normal and sensitized guinea-pig lymph node cells. Life Sci. 1962 Jul;1:347–352. doi: 10.1016/0024-3205(62)90131-5. [DOI] [PubMed] [Google Scholar]
  360. Ward P. A. A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med. 1967 Aug 1;126(2):189–206. doi: 10.1084/jem.126.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  361. Ward P. A., Becker E. L. Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response. J Immunol. 1970 Nov;105(5):1057–1067. [PubMed] [Google Scholar]
  362. Ward P. A., Becker E. L. Mechanisms of the inhibition of chemotaxis by phosphonate esters. J Exp Med. 1967 Jun 1;125(6):1001–1020. doi: 10.1084/jem.125.6.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Ward P. A., Becker E. L. Potassium reversible inhibition of leukotaxis by ouabain. Life Sci. 1970 Mar 22;9(6):355–360. doi: 10.1016/0024-3205(70)90180-3. [DOI] [PubMed] [Google Scholar]
  364. Ward P. A., Berenberg J. L. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med. 1974 Jan 10;290(2):76–80. doi: 10.1056/NEJM197401102900203. [DOI] [PubMed] [Google Scholar]
  365. Ward P. A. Chemotaxis of human eosinophils. Am J Pathol. 1969 Jan;54(1):121–128. [PMC free article] [PubMed] [Google Scholar]
  366. Ward P. A. Chemotoxis of mononuclear cells. J Exp Med. 1968 Nov 1;128(5):1201–1221. doi: 10.1084/jem.128.5.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  367. Ward P. A., Cochrane C. G., Muller-Eberhard H. J. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966 Aug;11(2):141–153. [PMC free article] [PubMed] [Google Scholar]
  368. Ward P. A., Cohen S., Flanagan T. D. Leukotactic factors elaborated by virus-infected tissues. J Exp Med. 1972 May 1;135(5):1095–1103. doi: 10.1084/jem.135.5.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  369. Ward P. A. Complement-derived leukotactic factors in pathological fluids. J Exp Med. 1971 Sep 1;134(3 Pt 2):109s–113s. [PubMed] [Google Scholar]
  370. Ward P. A., Hill J. H. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol. 1970 Mar;104(3):535–543. [PubMed] [Google Scholar]
  371. Ward P. A., Hill J. H. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol. 1970 Mar;104(3):535–543. [PubMed] [Google Scholar]
  372. Ward P. A. Insubstantial leukotaxis. J Lab Clin Med. 1972 Jun;79(6):873–877. [PubMed] [Google Scholar]
  373. Ward P. A., Lepow I. H., Newman L. J. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol. 1968 Apr;52(4):725–736. [PMC free article] [PubMed] [Google Scholar]
  374. Ward P. A. Leukotactic factors in health and disease. Am J Pathol. 1971 Sep;64(3):521–530. [PMC free article] [PubMed] [Google Scholar]
  375. Ward P. A. Leukotactic factors in health and disease. Am J Pathol. 1971 Sep;64(3):521–530. [PMC free article] [PubMed] [Google Scholar]
  376. Ward P. A. Leukotaxis and leukotactic disorders. A review. Am J Pathol. 1974 Dec;77(3):520–538. [PMC free article] [PubMed] [Google Scholar]
  377. Ward P. A., Remold H. G., David J. R. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol. 1970 Jul;1(2):162–174. doi: 10.1016/0008-8749(70)90003-1. [DOI] [PubMed] [Google Scholar]
  378. Ward P. A., Schlegel R. J. Impaired leucotactic responsiveness in a child with recurrent infections. Lancet. 1969 Aug 16;2(7616):344–347. doi: 10.1016/s0140-6736(69)92699-3. [DOI] [PubMed] [Google Scholar]
  379. Ward P. A., Talamo R. C. Deficiency of the chemotactic factor inactivator in human sera with 1 -antitrypsin deficiency. J Clin Invest. 1973 Feb;52(2):516–519. doi: 10.1172/JCI107209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  380. Ward P. A. The chemosuppression of chemotaxis. J Exp Med. 1966 Aug 1;124(2):209–226. doi: 10.1084/jem.124.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  381. Ward P. A., Zvaifler N. J. Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J Clin Invest. 1971 Mar;50(3):606–616. doi: 10.1172/JCI106531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Wasserman S. I., Goetzl E. J., Austen K. F. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol. 1974 Jan;112(1):351–358. [PubMed] [Google Scholar]
  383. Weinberg E. D. Iron and susceptibility to infectious disease. Science. 1974 May 31;184(4140):952–956. doi: 10.1126/science.184.4140.952. [DOI] [PubMed] [Google Scholar]
  384. Weiss A. S., Gallin J. I., Kaplan A. P. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb;53(2):622–633. doi: 10.1172/JCI107597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  385. Weissmann G., Dukor P., Zurier R. B. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol. 1971 Jun 2;231(22):131–135. doi: 10.1038/newbio231131a0. [DOI] [PubMed] [Google Scholar]
  386. Weissmann G. Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med. 1972 Jan 20;286(3):141–147. doi: 10.1056/NEJM197201202860307. [DOI] [PubMed] [Google Scholar]
  387. Weissmann G., Rita G. A. Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nat New Biol. 1972 Dec 6;240(101):167–172. doi: 10.1038/newbio240167a0. [DOI] [PubMed] [Google Scholar]
  388. Weissmann G., Spilberg I., Krakauer K. Arthritis induced in rabbits by lysates of granulocyte lysosomes. Arthritis Rheum. 1969 Apr;12(2):103–116. doi: 10.1002/art.1780120207. [DOI] [PubMed] [Google Scholar]
  389. Weissmann G., Zurier R. B., Hoffstein S. Leukocytic proteases and the immunologic release of lysosomal enzymes. Am J Pathol. 1972 Sep;68(3):539–564. [PMC free article] [PubMed] [Google Scholar]
  390. Weissmann G., Zurier R. B., Spieler P. J., Goldstein I. M. Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med. 1971 Sep 1;134(3 Pt 2):149s–165s. [PubMed] [Google Scholar]
  391. Weksler B. B., Coupal C. E. Platelet-dependent generation of chemotactic activity in serum. J Exp Med. 1973 Jun 1;137(6):1419–1430. doi: 10.1084/jem.137.6.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  392. Welch M. H., Guenter C. A., Hammarsten J. F. Precocious emphysema and alpha 1 antitrypsin deficiency. Adv Intern Med. 1971;17:379–392. [PubMed] [Google Scholar]
  393. Wenk E. J., Orlic D., Reith E. J., Rhodin J. A. The ultrastructure of mouse lymph node venules and the passage of lymphocytes across their walls. J Ultrastruct Res. 1974 May;47(2):214–241. doi: 10.1016/s0022-5320(74)80071-7. [DOI] [PubMed] [Google Scholar]
  394. Werb Z., Cohn Z. A. Plasma membrane synthesis in the macrophage following phagocytosis of polystyrene latex particles. J Biol Chem. 1972 Apr 25;247(8):2439–2446. [PubMed] [Google Scholar]
  395. Wilhelm D. L. Kinins in human disease. Annu Rev Med. 1971;22:63–84. doi: 10.1146/annurev.me.22.020171.000431. [DOI] [PubMed] [Google Scholar]
  396. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]
  397. Willis A. L. Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J Pharm Pharmacol. 1969 Feb;21(2):126–128. doi: 10.1111/j.2042-7158.1969.tb08213.x. [DOI] [PubMed] [Google Scholar]
  398. Windhorst D. B. Functional defects of neutrophils. Adv Intern Med. 1970;16:329–349. [PubMed] [Google Scholar]
  399. Winkelstein J. A., Drachman R. H. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med. 1968 Aug 29;279(9):459–466. doi: 10.1056/NEJM196808292790904. [DOI] [PubMed] [Google Scholar]
  400. Wintroub B. U., Goetzl E. J., Austen K. F. A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin. J Exp Med. 1974 Sep 1;140(3):812–824. doi: 10.1084/jem.140.3.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  401. Wissler J. H. Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties of classical anaphylatoxin from rat serum. Eur J Immunol. 1972 Feb;2(1):73–83. doi: 10.1002/eji.1830020115. [DOI] [PubMed] [Google Scholar]
  402. Wissler J. H. Chemistry and biology of the anaphylatoxin related serum peptide system. II. Purification, crystallization and properties of cocytotaxin, a basic peptide from rat serum. Eur J Immunol. 1972 Feb;2(1):84–89. doi: 10.1002/eji.1830020116. [DOI] [PubMed] [Google Scholar]
  403. Wissler J. H., Stecher V. J., Sorkin E. Chemistry and biology of the anaphylatoxin related serum peptide system. 3. Evaluation of leucotactic activity as a property of a new peptide system with classical anaphylatoxin and cocytotaxin as components. Eur J Immunol. 1972 Feb;2(1):90–96. doi: 10.1002/eji.1830020117. [DOI] [PubMed] [Google Scholar]
  404. Wolff S. M. The Chediak-Higashi syndrome: studies of host defenses. Ann Intern Med. 1972 Feb;76(2):293–306. doi: 10.7326/0003-4819-76-2-293. [DOI] [PubMed] [Google Scholar]
  405. Woodin A. M., Harris A. The inhibition of locomotion of the polymorphonuclear leucocyte by organophosphorus compounds. Exp Cell Res. 1973 Mar 15;77(1):41–46. doi: 10.1016/0014-4827(73)90550-8. [DOI] [PubMed] [Google Scholar]
  406. Woodin A. M., Wieneke A. A. Action of DFP the leucocyte and the axon. Nature. 1970 Aug 1;227(5257):460–463. doi: 10.1038/227460a0. [DOI] [PubMed] [Google Scholar]
  407. Woodin A. M., Wieneke A. A. Leukocidin, tetraethylammonium ions, and the membrane acyl phosphatases in relation to the leukocyte potassium pump. J Gen Physiol. 1970 Jul;56(1):16–32. doi: 10.1085/jgp.56.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  408. Wuepper K. D., Cochrane C. G. Plasma prekallikrein: isolation, characterization, and mechanism of activation. J Exp Med. 1972 Jan;135(1):1–20. doi: 10.1084/jem.135.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  409. Yoshida T., Cohen S., Bigazzi P. E., Kurasuji T., Amsden A. Inflammatory mediators in culture filtrates of Escherichia coli. Am J Pathol. 1975 Nov;81(2):389–400. [PMC free article] [PubMed] [Google Scholar]
  410. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  411. Zigmond S. H. Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature. 1974 May 31;249(456):450–452. doi: 10.1038/249450a0. [DOI] [PubMed] [Google Scholar]
  412. Zimmerman T. S., Müller-Eberhard H. J. Blood coagulation initiation by a complement-mediated pathway. J Exp Med. 1971 Dec 1;134(6):1601–1607. doi: 10.1084/jem.134.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  413. Zucker-Franklin D., Elsbach P., Simon E. J. The effect of the morphine analog levorphanol on phagocytosing leukocytes. A morphologic study. Lab Invest. 1971 Nov;25(5):415–421. [PubMed] [Google Scholar]
  414. Zurier R. B., Hoffstein S., Weissmann G. Cytochalasin B: effect on lysosomal enzyme release from human leukocytes. Proc Natl Acad Sci U S A. 1973 Mar;70(3):844–848. doi: 10.1073/pnas.70.3.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  415. Zurier R. B., Weissmann G., Hoffstein S., Kammerman S., Tai H. H. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest. 1974 Jan;53(1):297–309. doi: 10.1172/JCI107550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  416. da Silva W. D., Eisele J. W., Lepow I. H. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3. J Exp Med. 1967 Dec 1;126(6):1027–1048. doi: 10.1084/jem.126.6.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES